跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目251-275 / 12927. (共518頁) << < 6 7 8 9 10 11 12 13 14 15 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2020-05	A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data	Gastric Cancer. 2020 May;23(3):510-519.
2016-08-24	A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment	Journal of Biomedical Science. 2016 Aug 24;23:Article number 64.
2017-05	A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy	Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531.
2014-05	A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):2617.
2016-11-21	A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors	BMC Cancer. 2016 Nov 21;16:Article number 907.
2021-03	A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma	Oncologist. 2021 Mar;26(3):e367-e373.
2022-04	A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study	British Journal of Cancer. 2022 Apr;126(7):1018-1026.
2015-12	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial	Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
2015-05	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
2016-01	A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial	Medicine. 2016 Jan;95(3):Article number e2565.
2017-02	A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):417.
2021-09	A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer	Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.
2017-07	A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17	Oncotarget. 2017 Jul;8(27):44121-44130.
2019-02	A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number TPS468.
2020-02	A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data	Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 383.
2019-08-12	A piezoceramic sensor for detection of focused ultrasound-induced cavitation	IEEE Sensors Journal. 2019 Aug 12;19(22):10379-10385.
2024-07-01	A pilot study of 16-week intensive outpatient treatment for gay and bisexual men with methamphetamine use disorder in Taiwan	Drug and Alcohol Dependence. 2024 Jul 01;260(Suppl.):Meeting Abstract 110867.
2020-10-21	A polypeptide of tumor-associated antigen L6 with intrinsic adjuvant activity enhances antitumor immunity	Vaccines. 2020 Oct 21;8(4):Article number 620.
2022-10-10	A polysaccharide isolated from the herb bletilla striata combined with methylcellulose to form a hydrogel via self-assembly as a wound dressing	International Journal of Molecular Sciences. 2022 Oct 10;23(19):Article number 1201.
2022-02	A portable controllable compressive stress device to monitor human breast cancer cell protrusions at single-cell resolution	Frontiers in Bioengineering and Biotechnology. 2022 Feb;10:Article number 852318.
2019-04	A post-hoc study of D-Amino acid Oxidase in blood as an indicator of Post-stroke Dementia	Frontiers in Neurology. 2019 Apr;10:Article number 402.
2017-01	A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide	Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
2015-03-06	A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder	Scientific Reports. 2015 Mar 6;5:Article number 8813.
2022-02-01	A prediction model for tumor recurrence in stage II–III colorectal cancer patients: From a machine learning model to genomic profiling	Biomedicines. 2022 Feb 1;10(2):Article number 340.

顯示項目251-275 / 12927. (共518頁) << < 6 7 8 9 10 11 12 13 14 15 > >> 每頁顯示[10|25|50]項目